• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.77 0.24(7.97%) Jan 23, 4:00PM EST
    |After Hours : 2.89 Up 0.12 (4.33%) Jan 23, 7:09PM EST
    Add to Portfolio
    Prev Close:3.01
    Open:2.96
    Bid:N/A
    Ask:3.00 x 5000
    1y Target Est:12.00
    Beta:0.95
    Next Earnings Date:N/A
    Day's Range:2.72 - 2.99
    52wk Range:2.08 - 8.35
    Volume:1,882,766
    Avg Vol (3m):1,312,420
    Market Cap:154.39M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 7.97%154.39M
    LLY77.15B
    NVS234.30B
    SNY123.02B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,677.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.73
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback